We are live on ! Find out more
RDHL

Redhill Biopharma
RDHL

1 hedge funds and large institutions have $342K invested in Redhill Biopharma in 2013 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more capital invested

Capital invested by funds: $312K → $342K (+$30K)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
U
UBS
Switzerland
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$342K – – –
U
2
UBS
Switzerland
– -$1K – –

RDHL Hedge Fund Activity: Q4 2013 in Review

1 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q4 2013, worth a combined $342K — up 9.6% from $312K a quarter earlier.

Fund positioning in RDHL was balanced in Q4 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was UBS, cutting an estimated $1K.

  • 1 institutional investor held Redhill Biopharma (RDHL) as of Q4 2013, unchanged from Q3 2013.
  • Funds reported $342K of Redhill Biopharma stock for Q4 2013, up 9.6% quarter-over-quarter.
  • 0 funds opened new Redhill Biopharma positions in Q4 2013 and 0 closed out.
  • The largest Redhill Biopharma seller in Q4 2013 was UBS, an estimated $1K sold.

Based on aggregated 13F filings for Q4 2013.